Short Interest in Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Increases By 1,667.8%

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) was the target of a significant increase in short interest during the month of August. As of August 31st, there was short interest totaling 1,828,008 shares, an increase of 1,667.8% from the August 15th total of 103,406 shares. Currently, 1.5% of the shares of the company are sold short. Based on an average daily volume of 8,029,553 shares, the days-to-cover ratio is presently 0.2 days.

Analyst Ratings Changes

Separately, Loop Capital set a $1.00 target price on shares of Xtant Medical in a research note on Wednesday, September 2nd. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $1.00.

Institutional Trading of Xtant Medical

Hedge funds and other institutional investors have recently bought and sold shares of the company. Nantahala Capital Management LLC increased its holdings in shares of Xtant Medical by 500.3% in the second quarter. Nantahala Capital Management LLC now owns 68,394,000 shares of the medical device company’s stock worth $50,543,000 after purchasing an additional 57,000,000 shares during the period. AWM Investment Company Inc. bought a new stake in Xtant Medical during the second quarter valued at $2,516,000. Hillsdale Investment Management Inc. purchased a new position in Xtant Medical during the fourth quarter worth about $284,000. Nano Cap New Millennium Growth Fund L P bought a new position in Xtant Medical in the 4th quarter worth about $220,000. Finally, Renaissance Technologies LLC increased its stake in Xtant Medical by 28.8% in the 4th quarter. Renaissance Technologies LLC now owns 919,860 shares of the medical device company’s stock worth $721,000 after acquiring an additional 205,945 shares during the last quarter. Institutional investors own 69.33% of the company’s stock.

Xtant Medical Stock Performance

Shares of NYSEAMERICAN:XTNT traded up $0.01 during trading on Friday, hitting $0.35. 242,314 shares of the company were exchanged, compared to its average volume of 5,019,994. Xtant Medical has a 52-week low of $0.27 and a 52-week high of $0.95. The stock has a 50 day moving average of $0.39 and a 200 day moving average of $0.47. The company has a debt-to-equity ratio of 0.18, a current ratio of 2.16 and a quick ratio of 1.05. The company has a market cap of $49.10 million, a PE ratio of -4.37 and a beta of -0.15.

Xtant Medical (NYSEAMERICAN:XTNT) last released its quarterly earnings data on Tuesday, August 11th. The medical device company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.05). Xtant Medical had a negative net margin of 10.17% and a negative return on equity of 23.45%. The company had revenue of $23.03 million for the quarter, compared to the consensus estimate of $24.88 million.

Xtant Medical Company Profile

Xtant Medical, Inc is a medical technology company focused on the development, manufacturing and distribution of bone graft, spine biologics and related implantable medical devices. The company’s product portfolio is designed to address critical needs in spinal fusion, orthopedics and trauma surgery by providing a range of solutions that promote bone growth, structural support and patient recovery.

The company’s offerings include an array of bone graft substitutes – such as demineralized bone matrix putties and fibers – interbody fusion devices, spinal fixation systems and biologic agents.